L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase - sprookjes - yvandenbroek - TriplyDB

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

http://www.wikidata.org/entity/Q34400424

about

Acute lymphoblastic leukaemia L-asparaginase in the treatment of patients with acute lymphoblastic leukemia Cancer drug resistance: redox resetting renders a way Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase Increased Oxidative Stress as a Selective Anticancer Therapy Components of cancer metabolism and therapeutic interventions Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia Asparaginase pharmacokinetics and implications of therapeutic drug monitoring How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia Asparagine requirement in Plasmodium berghei as a target to prevent malaria transmission and liver infections.Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells Recent new drug approvals. Part 1: drugs with pediatric indications Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.Human 60-kDa lysophospholipase contains an N-terminal L-asparaginase domain that is allosterically regulated by L-asparagine.Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment.Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation Identification and functional characterization of a novel bacterial type asparagine synthetase A: a tRNA synthetase paralog from Leishmania donovani Effect of premedications in a murine model of asparaginase hypersensitivity Treatment of children with advanced-stage lymphoblastic lymphoma with pegaspargase L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence.Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells.Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity Modeling cancer metabolism on a genome scale.Directed Evolution of Enzymes for Industrial Biocatalysis.Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.The Emerging Hallmarks of Cancer Metabolism Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.A 50-year journey to cure childhood acute lymphoblastic leukemia Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.L-Asparaginase Isolated from Phaseolus vulgaris Seeds Exhibited Potent Anti-Acute Lymphoblastic Leukemia Effects In-Vitro and Low Immunogenic Properties In-Vivo.

P2860

Q24602387-54088DF4-5F3D-4FA3-B83F-11EE7B44F5A8 Q26738640-56BB9C8F-5E7C-4320-80FF-146F9E6BD348 Q26750753-1A9C9212-0150-4CD2-AD26-A3AFC78DB315 Q26784116-13D495CA-0CBB-4C1A-8C70-E11BAD733BF1 Q26798210-E46ED127-2872-4B9A-B4CF-8C70BB12062C Q26823746-29034E15-0894-4975-A978-BC4908A7C4F5 Q26825970-35A38017-9047-454C-94DC-3B531AF48501 Q27026476-13D170B9-9350-40B8-92CA-2129D264C112 Q27026952-69C16A9E-79F5-45DF-8491-5D5A010397AD Q27319073-F110A652-83CD-4FFD-86CE-6A0C4695775F Q28083449-4F308DE6-52A6-4317-922B-9F94D3AD565C Q28087637-8F4E8BAD-CD53-41A2-AF09-CCB78D557AC1 Q28114319-DE272064-10E3-46AC-9871-466BB2255A73 Q28550260-912C7930-5775-4AD1-AD80-C0D3FC004D90 Q28709081-6D90F0B5-4E88-4FC4-A599-8EAB9AF9F9BC Q30040775-A4C9969A-EFEE-46D2-A19E-A21605E3F569 Q30362969-565B6E1A-8E04-4F79-93B5-6C5D2DE3287D Q33676522-AF605110-4464-42D7-B49A-5845226B2852 Q33679931-B396AD84-D830-4BCA-B8AA-F99049C1BAEE Q34325815-65BA950A-F0C9-4FC5-9FD0-AADFF260C5DF Q34345494-7DD8E452-B3CF-40D6-A761-53DC55E87653 Q34568337-4785CE49-A08D-432D-A5EB-32861F08B851 Q35115121-EB853BF3-A820-4F68-9636-4F0FCFC45E26 Q35156439-EFBFC9DA-197F-41D8-87E8-01697721AE8A Q35177328-E7C2C134-DC8C-4F4E-80AD-A9D815DD9C17 Q35180579-B2559D6F-EFFC-472B-9FAA-38840400A8BE Q35551889-10734119-EA29-4EA0-8A78-18CF5AF479EE Q35803355-806E1D89-636B-46A4-B810-A925AC93D057 Q35850350-78E11F4A-FFA6-44AC-8525-258B03716CD3 Q35867710-35F05A40-3CC6-4DA0-BC7F-D9B3CE64CC56 Q36163029-6CD7D7B7-5B0D-4400-B364-D6709BF621A3 Q36405822-5B9BE426-7D22-48F7-95E1-2A3678CAC136 Q36468964-095475E1-4442-40F0-831B-F957484B76F6 Q36477909-F2A36203-0369-449B-8C46-B080080747FA Q36762608-73AC8D94-4E1A-4A49-BD49-99DD3B891E1E Q36805855-4EA2E4DF-3DFB-46AF-A87F-D7CC153D4F51 Q37046992-5C101F4E-B7DB-4450-A319-8EFB2EC65A96 Q37166753-5994D6F5-B9B8-4051-8B29-84392619B006 Q37227757-64A7CFF8-EF06-4790-A8AB-BBB4F75722A1 Q37379199-9F7B3901-7B25-4769-B096-E5B3B07F5FC1

P2860

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

http://www.wikidata.org/entity/Q34400424

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@ast

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@en

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@nl

type

label

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@ast

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@en

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@nl

prefLabel

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@ast

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@en

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@nl

P1433

Q34400424-470E070F-B023-400D-843E-619A28F8746C

P1476

Q34400424-B40EE4D0-1D1F-458D-85E4-9712352AE8A6

P2093

Q34400424-610B6A33-E6F8-44D3-A69A-9739B7639A04

Q34400424-83B9B807-DBC5-49DC-A05F-F8F418EC1CAA

Q34400424-C361EF5E-E678-499A-8E91-187DEC4CDF0C

Q34400424-C5CFB08C-DA6A-45A6-B723-E86FCD25DD0F

Q34400424-C78FD6C9-40F3-4D44-8406-F0940EAA06BF

P2860

Q34400424-06B9A109-43D7-4424-8134-6C999AA1C97B

Q34400424-074C602E-6740-4D1B-BC5F-466AF3418840

Q34400424-0AD218AB-6A44-4614-BAC4-8988CA0B3CE1

Q34400424-10C9571A-E2D9-4EE0-9779-D759B791842A

Q34400424-12D4AF57-901D-44DE-BBFD-C1E208882D1A

Q34400424-167274D0-150A-4714-A961-7D6D15C180B5

Q34400424-20CDCFB6-201B-45BF-B09E-2BEAC7AFF371

Q34400424-24A8E21E-039B-4B40-8238-726B23836C60

Q34400424-27F211B1-AD46-4E68-8F42-B8959590FBB5

Q34400424-2D3FDE90-4520-4C46-BEBF-FFAE9DFFDE2D

P304

Q34400424-01F7DD0F-4BA0-4904-8037-F5D1E90CACCA

P31

Q34400424-EFCA2565-9983-407C-A75A-AE573951FC65

P356

Q34400424-26D56A68-8744-402C-9A9F-46AE618BC07C

P407

Q34400424-1CCE27E7-7780-4AF7-9211-39DA6865F3BC

P433

Q34400424-D32323EC-E251-4C50-935A-928FECD75903

P478

Q34400424-508AFD1D-E3EF-4F24-8148-DFCEC82DA596

P50

Q34400424-5C9867DF-7C30-4F63-8F76-CC30AD62F2D7

Q34400424-6AFE3445-C2FD-40BD-9C8E-3FDDE173E72A

Q34400424-D2B3A49E-F422-4F06-864C-39EC7B41908C

Q34400424-F5CDCF94-F5A1-4819-B88A-3C8E791E3355

P577

Q34400424-4E9F8640-F806-44B3-A645-A412BCB4DBBE

P5875

Q34400424-1224E32A-6273-48A9-A867-A3AE352C8C08

P698

Q34400424-474C8D77-F64B-45FC-A3FD-783C9AA8F8DA

P921

Q34400424-11928157-D14F-4099-9F57-3728E5A94F2E

P932

Q34400424-D8DB0E22-44BB-4AD0-A36C-E890F1D27909

P356

P1433

P1476

L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase

@en

P2093

Andre Baruchel

http://www.w3.org/2001/XMLSchema#string

Carmelo Rizzari

http://www.w3.org/2001/XMLSchema#string

Joachim Boos

http://www.w3.org/2001/XMLSchema#string

Lewis Silverman

http://www.w3.org/2001/XMLSchema#string

Nicola Goekbuget

http://www.w3.org/2001/XMLSchema#string

P2860

Treating childhood acute lymphoblastic leukemia without cranial irradiation

L-Asparaginase: discovery and development as a tumor-inhibitory agent

Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.

Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia

PEG-asparaginase.

Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.

Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia.

P304

238-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25489

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Stephen P Hunger

Martin Schrappe

P577

2010-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46171429

http://www.w3.org/2001/XMLSchema#string

P698

20824725

http://www.w3.org/2001/XMLSchema#string

P921

P932

3000881

http://www.w3.org/2001/XMLSchema#string